Jubilant Life Sciences extends rally post Q1 results
The stock hit a record high of Rs 474, surging 44% in past seven trading sessions, as compared to 0.13% fall in Sensex.18-08-2016
Jubilant Life Sciences extends rally post Q1 results
The stock hit a record high of Rs 474, surging 44% in past seven trading sessions, as compared to 0.13% fall in Sensex.Buy Jubilant Life Sciences Ltd., target Rs 484.0 : Prabhudas Lilladher
Prabhudas Lilladher pegged Jubilant Life Sciences PE at 11.1x FY17 and 9.6x FY18 estimated earnings.Jubilant Life Sciences profit up 22% to Rs162 crore in Q1
Revenues declined 2% to Rs1,420 crore in the quarter ended JuneAnnounces Q1 (Standalone & Consolidated) results, Limited Review Report (Standalone & Consolidated), Results Press Release & Presentation for the Quarter ended June 30, 2016
Jubilant Life Sciences Ltd has announced the following results for the quarter ended June 30, 2016:The Unaudited Standalone results for the Quarter ended June 30, 2016The Company has posted a net profit of Rs. 209.80 million for the quarter ended June 30, 2016 as compared to Rs. 28.40 million for the quarter ended June 30, 2015. Total Income has decreased from Rs. 6822.00 million for the quarter ended June 30, 2015 to Rs. 5916.80 million for the quarter ended June 30, 2016....AGM on Aug 30, 2016
Jubilant Life Sciences Ltd has informed BSE that the 38th Annual General Meeting (AGM) of the Company will be held on August 30, 2016.Fixes Book Closure for Dividend & AGM
Jubilant Life Sciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 20, 2016 to August 30, 2016 (both days inclusive) for the purpose of Payment of Dividend & 38th Annual General Meeting (AGM) of the Company to be held on August 30, 2016.The Dividend on equity shares @ Rs.3 per equity share of Re.1 each, as recommended by the Board of Directors, if declared at the AGM,...Schedule of Investor Conference Call
Jubilant Life Sciences Ltd has informed BSE regarding Schedule of Investor Conference Call.Q1 results on August 09, 2016
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 09, 2016, inter alia, to consider Unaudited Financial Results of the Company for the quarter ended June 30, 2016 (Q1).Further, as per the Companys Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company would remain closed for the Designated...Buy Jubilant Life Sciences, target Rs 318: Microsec Capital
Buy Jubilant Life Sciences Ltd. at a price target of Rs 318 and a stop loss at Rs 309Shareholding for the Period Ended June 30, 2016
Jubilant Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here